START Midwest is part of START's global network of Phase I Clinical Research sites. This program offers cancer patients in the Midwest of the United States access to experimental treatments and therapies. START Midwest is able to offer hope to patients facing the toughest cancer battles, while also helping to advance cancer research.
START Research by
Square feet of world-class research facilities
Oncology Drugs Brought To Market
Locations across the United States and Europe
START Research Capabilities
Phase I Clinical Trials
This is where we test cancer drugs in human beings for the first time. With 13,000 square feet of testing facilities, START is a global leader in phase I cancer research
START performs clinical research to find new candidates for potential anti-cancer compounds. 27 drugs brought to market is only the beginning
Your START Research Team
The Doctors on the START Research Team are dedicated to developing novel anti-cancer agents. With their expertise and dedication to this science, patients around the world will have new and more effective opportunities to treat their cancers.